04/07/2024
11:15 PM | Checkpoint Therapeutics (Filer)
| Form EFFECT | |
04/02/2024
5:00 AM | Checkpoint Therapeutics (Filer)
| Form DEF 14A | |
04/02/2024
5:03 AM | Checkpoint Therapeutics (Filer)
| Form DEFA14A | |
03/29/2024
4:03 PM | Checkpoint Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/22/2024
5:23 PM | Checkpoint Therapeutics (Issuer)
Fortress Biotech, Inc. (Reporting)
Fortress Biotech, Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
5:24 PM | Checkpoint Therapeutics (Subject)
Fortress Biotech, Inc. (Filed by)
Fortress Biotech, Inc. (Filed by)
| Form SC 13D/A | |
03/22/2024
4:19 PM | Checkpoint Therapeutics (Filer)
| Form PRE 14A | |
|
03/22/2024
4:13 PM | Checkpoint Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/22/2024
7:52 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
7:00 PM | Amit Sharma (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/01/2024
7:30 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
7:31 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
1:24 PM | ARMISTICE CAPITAL, LLC (Filed by)
Checkpoint Therapeutics (Subject)
| Form SC 13G/A | |
02/05/2024
4:00 PM | Checkpoint Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/02/2024
7:15 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
7:05 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/02/2024
7:10 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:15 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2024
4:00 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
4:01 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
6:10 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2023
11:15 PM | Checkpoint Therapeutics (Filer)
| Form EFFECT | |
11/13/2023
4:15 PM | Checkpoint Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2023
4:10 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2023
3:16 PM | Checkpoint Therapeutics (Issuer)
Fortress Biotech, Inc. (Reporting)
Fortress Biotech, Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/26/2023
3:16 PM | Checkpoint Therapeutics (Subject)
Fortress Biotech, Inc. (Filed by)
Fortress Biotech, Inc. (Filed by)
| Form SC 13D/A | |
08/14/2023
3:30 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2023
7:23 AM | Checkpoint Therapeutics (Filer)
| Form 424B5 | |
07/31/2023
7:28 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/27/2023
6:30 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/06/2023
3:44 PM | Checkpoint Therapeutics (Subject)
Fortress Biotech, Inc. (Filed by)
Fortress Biotech, Inc. (Filed by)
| Form SC 13D/A | |
07/03/2023
12:15 PM | Checkpoint Therapeutics (Issuer)
Fortress Biotech, Inc. (Reporting)
Fortress Biotech, Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
7:00 PM | Bechon Christian (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
7:00 PM | Boilen Scott (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
7:00 PM | Checkpoint Therapeutics (Issuer)
Herskowitz Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
7:00 PM | Checkpoint Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
7:01 PM | Checkpoint Therapeutics (Issuer)
SALZMAN BARRY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
7:01 PM | Checkpoint Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
6:00 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2023
4:24 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2023
4:25 PM | Checkpoint Therapeutics (Filer)
| Form 424B5 | |
Gold Mania (Ad) Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential
He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite). See his free reveal right here. |
05/07/2023
11:15 PM | Checkpoint Therapeutics (Filer)
| Form EFFECT | |
05/07/2023
11:15 PM | Checkpoint Therapeutics (Filer)
| Form EFFECT | |
05/07/2023
11:15 PM | Checkpoint Therapeutics (Filer)
| Form EFFECT | |
